
Copernicium Pharmaceuticals Private Limited
Pharmaceutical trading and business consultancy services provider incorporated in 2013.
Pharmaceutical trading and business consultancy services provider incorporated in 2013.
Copernicium Pharmaceuticals Private Limited (CPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 December 2013 and has a history of 11 years and five months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.60 Cr and a paid-up capital of Rs 3.58 Cr.
The company currently has active open charges totaling ₹29.21 Cr.
Akash Puranik and Salim Shaikh serve as directors at the Company.
Bangaluru, Karnataka, India
+91-XXXXXXXXXX
U24230KA2013PTC072419
072419
Private Limited Indian Non-Government Company
10 Dec 2013
30 Sep 2024
31 Mar 2024
Unlisted
Roc Bangalore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Akash Puranik ![]() | Director | 23-Dec-2013 | Current |
Salim Shaikh ![]() | Director | 10-Dec-2013 | Current |
Copernicium Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 13.78% decrease. The company also saw a slight improvement in profitability, with a 4.34% increase in profit. The company's net worth Soared by an impressive increase of 173.61%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Copernicium Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Akash Puranik and Salim Shaikh are mutual person
Akash Puranik and Salim Shaikh are mutual person
Salim Shaikh is a mutual person
Akash Puranik and Salim Shaikh are mutual person
Akash Puranik and Salim Shaikh are mutual person
Salim Shaikh is a mutual person
₹29.21 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
28 Nov 2022 | Others | ₹28.00 Cr | Open |
01 Sep 2021 | Hdfc Bank Limited | ₹2.97 M | Open |
16 Sep 2020 | Hdfc Bank Limited | ₹1.00 M | Open |
28 Aug 2020 | Hdfc Bank Limited | ₹1.00 M | Open |
28 Aug 2020 | Hdfc Bank Limited | ₹3.70 M | Open |
Copernicium Pharmaceuticals has a workforce of 8 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Copernicium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Copernicium Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Copernicium Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Copernicium Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
A charge with Others of Rs. 28.00 Cr registered on 28 Nov 2022 with Charge ID 100649377 was modified on 28 Jun 2023.
A charge with Others amounted to Rs. 28.00 Cr with Charge ID 100649377 was registered on 28 Nov 2022.
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100478369 was registered on 01 Sep 2021.
A charge with Hdfc Bank Limited amounted to Rs. 0.10 Cr with Charge ID 100429488 was registered on 16 Sep 2020.
Copernicium Pharmaceuticals Private Limited was incorporated on 10 Dec 2013.
The authorized share capital of Copernicium Pharmaceuticals Private Limited is ₹ 3.60 Cr and paid-up capital is ₹ 3.58 Cr.
Currently 2 directors are associated with Copernicium Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Copernicium Pharmaceuticals Private Limited is Sree Veerabhadreshwara Swamy Enclave No. 1215 24Th Main 11Th Cross Hsr Layout, 1St S Ector India, Bangalore, Karnataka, 560102.
The corporate identification number (CIN) of Copernicium Pharmaceuticals Private Limited is U24230KA2013PTC072419 and the company number is 072419 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Copernicium Pharmaceuticals Private Limited has fallen by -13.78%.
As Per 2022 financial reports, 8 employees are currently employed by Copernicium Pharmaceuticals Private Limited.
The financial reports for the fiscal year 2022 indicates that The net worth of Copernicium Pharmaceuticals Private Limited has experienced an upsurge of 173.61%.
As per the financial statements for fiscal Year 2022, The total open charges for Copernicium Pharmaceuticals Private Limited amount to ₹ 29.21 Cr.
The most recent Balance Sheet for Copernicium Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
AK